Edmond de Rothschild (Suisse)’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q4
Sell
-399,000
Closed -$1.4M 455
2015
Q3
$1.4M Buy
399,000
+349,000
+698% +$1.23M 0.47% 52
2015
Q2
$499K Buy
+50,000
New +$499K 0.16% 112